Pharma-Bio Serv, Inc.
PBSV
$0.59
$0.024.07%
OTC PK
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.50% | -18.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.50% | -18.78% | |||
| Cost of Revenue | 0.86% | -13.11% | |||
| Gross Profit | 30.40% | -29.85% | |||
| SG&A Expenses | -0.66% | -3.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.26% | -9.48% | |||
| Operating Income | 57.53% | -219.33% | |||
| Income Before Tax | 102.06% | -307.14% | |||
| Income Tax Expenses | 191.67% | -187.27% | |||
| Earnings from Continuing Operations | 99.95% | -314.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 99.95% | -314.15% | |||
| EBIT | 57.53% | -219.33% | |||
| EBITDA | 60.58% | -274.97% | |||
| EPS Basic | 100.00% | -311.90% | |||
| Normalized Basic EPS | 101.75% | -311.11% | |||
| EPS Diluted | 100.00% | -325.00% | |||
| Normalized Diluted EPS | 101.75% | -311.11% | |||
| Average Basic Shares Outstanding | 0.08% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.03% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||